ASHLEY CHAIKEN: Open Payments
NPI 1699004150 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 58 payments from 17 companies in 2025. Trend: 2023 $1,121 · 2024 $1,044 · 2025 $1,282
Food & beverage: $1,282
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 8 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $189 |
| ABBVIE INC. | 11 | $156 |
| Gilead Sciences, Inc. | 6 | $151 |
| Madrigal Pharmaceuticals | 5 | $146 |
| Janssen Biotech, Inc. | 5 | $107 |
| Lilly USA, LLC | 3 | $61 |
| Celltrion USA Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $44 |
| Intercept Pharmaceuticals, Inc. | 2 | $41 |
Products named: IBSRELA, ENTYVIO, REZDIFFRA, TREMFYA, RINVOQ, OMVOH, VEGZELMA, Wegovy.
Industry payments across FL — which companies pay providers there.
